Morinaga Milk Industry Co., Ltd.
Japanese dairy company supplying a Bifidobacterium longum probiotic strain and a postbiotic ingredient.
- MOQ
- Not publicly disclosed
- LEAD TIME
- Not publicly disclosed
Overview
Morinaga Milk Industry Co., Ltd. is one of Japan's leading dairy companies with over a century of history, headquartered in Tokyo. The company's probiotic division supplies Bifidobacterium longum BB536, one of the most well-documented probiotic strains worldwide with over 260 published scientific studies and more than 50 years of commercial use. BB536 has FDA GRAS notification for conventional foods (2009), infant formula (2020), and infants (self-affirmed 2019). Morinaga also produces the LAC-Living+ postbiotic ingredient. The company operates a US subsidiary, Morinaga Nutritional Foods, Inc., and also distributes ingredients in the US market through Maypro Industries. BB536 is marketed in over 30 countries.
Certifications
Certification verification in progress. International supplier records require regional database lookups (EudraGMDP, Health Canada NHP, FSSC public register, JHFA directory). See our methodology.
INGREDIENT REGULATORY STATUS
- FDA GRAS Notification (Foods, Infant Formula, Infants)FDA GRAS notice, FDA had no questions: Bifidobacterium longum BB536, in conventional foods (GRN 268) · source
- FDA GRAS notice, FDA had no questions: Bifidobacterium longum BB536, in term infant formula (GRN 877) · source
- FDA GRAS notice, FDA had no questions: Bifidobacterium breve M-16V, in conventional foods (GRN 453) · source
- FDA GRAS notice, FDA had no questions: Bifidobacterium breve M-16V, in powdered term infant formula (GRN 454) · source
- FDA GRAS notice, FDA had no questions: Bifidobacterium breve MCC1274, in conventional foods (GRN 1002) · source
- FDA GRAS notice, FDA had no questions: Bifidobacterium infantis M-63, in term infant formula and certain conventional foods (GRN 1003) · source
- FDA GRAS notice, FDA had no questions: Lactoferrin, in cow's milk-based foods and chewing gum (GRN 464) · source
- FDA GRAS notice, FDA had no questions: Lactoferrin, in cow's milk-based term infant formula (GRN 465) · source
Capabilities
- PRODUCT TYPES
- Bifidobacterium longum BB536 (Probiotic Strain) · LAC-Living+ (Postbiotic) · Human-Residential Bifidobacteria (HRB) Strains
- CAPABILITIES
- Branded or patented ingredients · Clinical research or study support · Probiotics or postbiotics · North American distribution or office
Sources
What we couldn't verify
We did not visit this company on site. See the limits that apply to every listing.
- Headquarters in Tokyo, Japan; US subsidiary Morinaga Nutritional Foods Inc.
- Large dairy conglomerate. Probiotic ingredients are one division
- Also distributed through Maypro Industries in some markets
- Certification details beyond cGMP not independently verified from public databases
Dietary supplement manufacturers must comply with 21 CFR Part 111 (cGMP). What Part 111 requires
The connection map between Morinaga Milk Industry Co., Ltd. and other vendors, capabilities, and certifications is in the manufacturer atlas.
Enforcement screening: included in Inventory Ready's most recent completed pass against FDA's published recall datasets (2026-07-09). Method and limits →
Interested in Morinaga Milk Industry Co., Ltd.?
Tell us about your project and we'll help you determine if this ingredient supplier is a good fit.